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Abstract 
A series of 5-(3-substituted-thiophene)-pyrimidine derivatives (3a-d) 
were synthesized via Knoevenagel condensation reaction in aqueous 
ethanol using H2O2:HCl as a catalyst. Their pharmacological effects 
were evaluated. Analytical and spectroscopic methods confirmed the 
structures of the target molecules. The antibacterial activity studies 
revealed that compounds 3b and 3d exhibited the most effective zone 
of inhibition against bacterial strains E. coli and S. aureus, 
respectively. The in vitro cytotoxicity was carried out by MTT assay 
against MCF-7 cell line. The results showed the excellent selectivity 
for all four compounds, among which the compound 3a exhibited re-
markable cytotoxicity with a minimum cell viability range of 23.68 to 
44.16%. The interaction of compounds with calf thymus DNA was de-
termined using UV-absorption spectroscopy. The results confirmed 
that all the synthesized compounds interacted strongly with CT DNA 
through electrostatic or groove binding. In silico ADME-toxicology 
studies indicated that all the molecules under investigation are non-
toxic with good oral bioavailability. The drug-likeness score indicat-
ed that they are suitable as drug-leads. In silico molecular docking 
the specified compound 3b bounds with GlcN-6-P and P38 MAPk with 
a minimum binding energy of –7.9 and –6.4 kcal/mol, respectively. 
DFT study demonstrated that the compound 3d was chemically and 
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1. Introduction
Heterocyclic compounds play a predominant role in medic-
inal chemistry and synthetic organic chemistry due to 
their massive biological importance. The synthesis of ni-
trogen and sulphur containing fused heterocyclic com-
pounds with multi-structures in one molecule has attract-
ed the attention of medicinal chemists and researchers 
due to their multifaceted pharmacological activities [1–2]. 
Among them, pyrimidine and thiophene have been recog-
nized as key scaffolds owing to their important biological 
significances and interesting therapeutic properties in-
cluding anti-tubercular [3], anticancer [4], anti-HIV [5], 
antibacterial [6], antifungal [7], antitumor [8], also used 
as potent EGFR inhibitor [9, 10], protein kinase inhibitors 
[11–14] and 5-HT7 receptors [15]. 
Moreover, the heterocyclic compounds increase the 
strength of the molecules by forming hydrogen bonds with 
DNA. Hence, the interactive study of heterocyclic moieties 
with DNA is essential for estimating their anticancer activ-
ity and elucidates the viable mechanism of their action. 
Therefore, DNA binding is considered as an essential ex-
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perimental step to measure anticancer drugs activity be-
cause most anticancer drugs specifically target the DNA 
[16]. Heterocyclic compounds appear to be most effective 
against various cancers. Around 60% of the medicines 
used for cancer treatment are based on heterocyclic moie-
ties. Among the various heterocyclic moieties, nitrogen 
and sulphur-based compounds are effective against differ-
ent types of cancers [17–19]. 
Cancer is a group of diseases in which the abnormal cells 
grow uncontrollably by disregarding the normal rules of cell 
division. Cancer is caused by many external (tobacco, chemi-
cals, radiation and infectious organisms) as well as some in-
ternal factors (inherited mutations, hormones, immune condi-
tions and random mutations). There are different types of can-
cer such as breast cancer, bladder cancer, kidney cancer, leu-
kaemia, liver cancer, lung cancer, melanoma, pancreatic can-
cer, prostate cancer, thyroid cancer etc. [20]. The breast can-
cer is one of the most frequently diagnosed cancers and the 
leading cause of death in females worldwide, with more than 
1.5 million new cases recorded every year. It is also the fifth-
highest cause of death in the world [21]. The modern methods 
of chemotherapy suffer from the main disadvantages: side 
effects and drug resistance. Therefore, continued search for 
novel and safer anticancer drugs remains essential [22].  
Pollution is one of the critical problems that the syn-
thetic organic chemist faces in designing the organic reac-
tions for the synthesis of pharmacologically active com-
pounds. Thus, development of an environmentally-friendly 
chemical process that induces necessary organic transfor-
mation is one of the most important goal of sustainable 
progression [23]. Therefore, "green chemistry" becomes a 
promising approach that meets the requirements of the 
chemical and pharmaceutical industries. The replacement 
of hazardous solvents with eco-friendly solvents is an ac-
ceptable and valuable approach in a chemical reaction. 
Hence, the use of a hypochlorous acid (HOCl) as a green 
halogenating agent [24] is highly advantageous over other 
catalysts, including cost-effectiveness, efficiency and read-
ily availability. Earlier, our research group has reported 
the synthesis of different pyrimidine derivatives and other 
biologically important heterocyclic compounds [25–27]. 
Some of the drugs containing pyrimidine nucleus available 
in the market are depicted below (Fig. 1). 
Based on the above findings, we herein report the ap-
plication of H2O2:HCl as a green halogenating catalyst for 
the synthesis of 5-(3-substituted-thiophene)-pyrimidine 
derivatives of considerable pharmacological relevance. 
2. Experimental 
2.1. Materials and Method 
All chemicals and calf thymus DNA were purchased from Al-
drich Chemical Company, and the reaction was performed at 
refluxed condition and solvents were used without further 
purification. Analytical TLC was performed with E. Merck 
silica gel GF254 glass plates. Visualization of the developed 
chromatogram was performed by UV light (254 and 356 nm). 
The melting points of the products were determined in open 
capillary tubes and uncorrected. The ATR-IR spectra were 
obtained using Bruker FTIR Alpha spectrometer. The 1H NMR 
and 13C NMR spectra were recorded on Bruker 400 MHz and 
100 MHz in DMSO-d6 as a solvent. Mass spectra were ob-
tained by Agilent 1200 series LC and Micromass Q spectrome-
ter. The DNA binding studies were carried on Elico SL 159 
UV-Visible spectrophotometer in 200–500 nm range 
equipped with 1.0 cm quartz cell at room temperature. The 
anticancer activity was carried out in the Department of Mi-
crobiology, Maratha Mandal's NGH Institute of Dental Sci-
ences and Research Centre, Belgaum, Karnataka. The compu-
tational studies were carried out by Density functional theory 
(DFT)/B3LYP method using Gaussian 09 software using 6-
31G (d, p) basis set at gaseous phase. 
2.2. General procedure for the synthesis of 5-(3-
substituted-thiophene)-pyrimidine derivatives (3a-d) 
The synthesis of 5-(3-substituted-thiophene)-pyrimidine 
derivatives (3a-d) were carried out by the reaction of bar-
bituric/thiobarbituric acid (1, 1mmol) with 3-substituted-
thiophene-2-carboxaldehyde (2, 1mmol) in the presence of 
15 mL aqueous ethanol using 6% H2O2:HCl (2:1) as a cata-
lyst. The reaction mixture was refluxed at 80 °C for about 
10–15 min and the progress of the reaction was monitored 
by TLC (Ethyl acetate and Petroleum ether). After the 
completion of the reaction, the reaction mixture was 
cooled to room temperature and poured into the 100 mL 
flake ice with vigorous stirring to get solid precipitated 
out. The crude mixture was filtered, washed and recrystal-
lized with absolute ethanol to afford pure solid products. 
2.2.1. 5-(Thiophen-2-ylmethylidene)pyrimidine-
2,4,6(1H,3H,5H)-trione (3a) 
Yield: 96%, Yellow solid; MP: 280–282 °C. IR (ATR,  
υ cm–1): 3373 (NH), 1654 (C=O), 1529 (C=C). 1H NMR 
(400 MHz, DMSO-d6, δ ppm): 7.31–7.33 (t, J= 8 Hz, 1H, Ar-H), 
8.13–8.24 (m, 2H, Ar-H), 8.53 (s, 1H, CH), 11.17 (s, 1H, NH), 
11.21 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6, δ ppm): 
112.035, 128.808, 136.776, 142.526, 146.116, 146.291, 
150.679, 163.453 and 163.950 (C=O). HRMS: m/z 221.9054 
[M+H]+. Anal. Calcd for C9H6N2O3S: C 48.64, H 2.72 and N 
12.61%. Found: C 48.59, H 2.68 and N 12.53%. 
2.2.2. 5-[(3-Methylthiophen-2-yl)methylidene]pyrimidine-
2,4,6(1H,3H,5H)-trione (3b) 
Yield: 94%, Yellow solid; MP: 302–306 °C. IR (ATR,  
υ cm–1): 3225 (NH), 2858 (CH3), 1703 (C=O), 1542 (C=C). 1H 
NMR (400 MHz, DMSO-d6, δ ppm): 2.24 (s, 3H, CH3), 7.21–7.23 
(d, J= 8 Hz, 1H, Ar-H), 8.16–8.18 (d, J= 8 Hz, 1H, Ar-H), 8.53 (s, 
1H, CH), 11.17 (s, 1H, NH), 11.24 (s, 1H, NH). 13C NMR (100 
MHz, DMSO-d6, δ ppm): 19.922 (CH3), 114.870, 135.252, 
136.011, 145.166, 147.180, 154.915, 158.106, 167.728 and 
168.497 (C=O). HRMS: m/z 235.9774 [M+H]+. Anal. Calcd for 
C10H8N2O3S: C 50.84, H 3.41 and N 11.86%. Found: C 50.79, H 
3.36 and N 11.80%. 
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Fig. 1 Some of the drugs containing pyrimidine nucleus available in the market 
2.2.3. 5-(Thiophen-2-ylmethylidene)-2-
thioxodihydropyrimidine-4,6(1H,5H)-dione (3c) 
Yield: 93%, Green solid; MP: 320–322 °C. IR (ATR,  
υ cm–1): 3106 (NH), 1760 (C=O), 1559 (C=C), 1156 (C=S). 
1H NMR (400 MHz, DMSO-d6, δ ppm): 6.86–6.88 (d,  
J = 8 Hz, 1H, Ar-H), 8.20 (s, 1H, CH), 8.34–8.36 (d,  
J = 8 Hz, 2H, Ar-H), 12.20 (s, 1H, NH), 12.30 (s, 1H, NH). 
13C NMR (100 MHz, DMSO-d6, δ ppm): 114.713, 116.139, 
124.434, 139.254, 157.012, 160.480, 162.825, 164.168 
(C=O) and 178.617 (C=S). HRMS: m/z 237.9467 [M+H]+. 
Anal. Calcd for C9H6N2O2S2: C 45.36, H 2.54 and N 11.76%. 
Found: C 45.30, H 2.49 and N 11.71%. 
2.2.4. 5-[(3-Methylthiophen-2-yl)methylidene]-2-
thioxodihydropyrimidine-4,6(1H,5H)-dione (3d) 
Yield: 95%, Green solid; MP: 310–312 °C. IR (ATR, υ cm–1): 
3108 (NH), 2852 (CH3), 1704 (C=O), 1516 (C=C), 1200 
(C=S). 1H NMR (400 MHz, DMSO-d6, δ ppm): 2.24 (s, 3H, 
CH3), 7.22–7.24 (d, J= 8 Hz, 1H, Ar-H), 8.17–8.19 (d,  
J = 8 Hz, 1H, Ar-H), 8.54 (s, 1H, CH), 11.18 (s, 1H, NH), 
11.25 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6, δ ppm): 
26.806 (CH3), 114.280, 128.031, 128.903, 129.867, 130.391, 
130.892, 142.472, 163.552 (C=O) and 173.358 (C=S). 
HRMS: m/z 251.9608 [M+H]+. Anal. Calcd for 
C10H8N2O2S2: C 47.60, H 3.20 and N 11.10%. Found: C 
47.55, H 3.16 and N 11.06%. 
2.3. Pharmacological studies 
2.3.1. Antibacterial activity  
Antibacterial activity of the synthesized compounds (3a-d) 
was carried out by the agar well diffusion method [28] 
using two bacterial strains (Gram-negative and Gram-
positive) Escherichia coli (MTCC-1559) and Staphylococ-
cus aureus (MTCC-902). DMSO was used as negative con-
trol and Ciprofloxacin as standard drug. The test com-
pounds were dissolved in DMSO at two different concen-
trations, 20 and 40 µg/mL. 
2.3.2. Cytotoxicity  
In vitro cytotoxicity was assessed by the MTT assay meth-
od [29] against MCF-7 (Breast cancer) cell line. The cells 
were seeded in a 96-well flat-bottom microplate and 
maintained at 37 °C in 95% humidity and 5% CO2 over-
night. Different concentration (200, 100, 50, 25, 12.5 and 
6.25 µg/mL) of samples were treated. The cells were incu-
bated for another 48 h, and the wells were washed twice 
with PBS. 20 µL of the MTT staining solution was added to 
each well, and the plate was incubated at 37 °C for 4 h. 
The medium with MTT was discarded, and 100 µL of 
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DMSO was added to each well to dissolve the formazan 
crystals. The absorbance was recorded at 570 nm using a 
microplate reader. The percentage of cell survival was 
calculated by using the following formula: 
% of cell survival =
Mean O. D. of test compound 
Mean O. D. of Negative control 
 100. (1) 
2.3.3. DNA binding study  
DNA binding study was assessed by using electronic spec-
troscopy. A solution of CT DNA in 50 mM Tris-HCl/50 mM 
NaCl buffer solution was prepared at pH 6.9–7.01. In buff-
er solution, the ratio of absorption values of CT DNA at 
260 and 280 nm is 1.8–1.9, indicating that DNA was free 
of proteins [30]. Then a concentrated stock solution of 
DNA was prepared in 50 mM Tris-HCl, 50 mM NaCl in 
double distilled water at pH 6.9–7.01. The concentration of 
CT DNA was determined per nucleotide by taking the ab-
sorption coefficient (6600 dm3 mol–1 cm–1) at 260 nm [31]. 
Stock solutions were stored at 4 °C. 2 mL of the solution 
was taken containing a fixed concentration of the com-
pounds (3a-d) with CT DNA (0 to 350 µL of a  
0.5025–6.067010–7 M stock CT DNA solution). A blank 
solution containing the same concentration of DNA was 
used as a reference. Solutions were prepared by mixing 
the compound and CT DNA in DMSO medium and then 
recording the UV absorption spectra by adding 25 to 
350 µL DNA to the compound. The spectra were recorded 
against a blank solution containing the same concentration 
of DNA (4.090910–6 mol L–1). The intrinsic binding con-
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 versus [DNA] gave a slope of 
1
(∈B−∈F)
 and  
Y-intercept equal to 
1
Kb(∈B−∈F)
. Hence Kb is the ratio of slope 
to intercept. The % of hyperchromicity or hypochromicity 
(% H) for the CT DNA/[Ligand] was obtained from  
(∈A – ∈F)/ ∈F 100. 
2.3.4. In silico oral bioavailability assessment and ADME-
toxicology studies  
The oral bioavailability of the synthetic molecules (3a-d) 
can be predicted by considering their structural properties 
to screen based on the Rule of five or Lipinski rule-of-five 
(RO5) filter [33]. Rule of five employs the molecular prop-
erties necessary to filter candidate drug's pharmacokinet-
ics (PK) and pharmacodynamics (PD) [34–36]. 
Oral bioavailability assessment was done using Osiris 
Data warrior V.4.4.3 [37] based on total molecular weight, 
ClogP, H-acceptors, H-donors, rotatable bonds as part of 
RO5 filters, along with TPSA (Topological polar surface ar-
ea) and drug-likeness assessment [38]. Pharmacodynamic 
properties like mutagenicity, tumorigenicity, reproductive 
effects, irritancy, Ames toxicity and hepatotoxicity were 
predicted using the admetSAR server. Bioactivity scores 
were predicted using the molinspiration server for GPCR 
ligand, ion channel modulator, kinase inhibitor, nuclear 
receptor inhibitor, protease inhibitor, enzyme inhibitor. 
Pharmacokinetic properties like blood-brain barrier pene-
tration, human intestinal absorption, Caco-2 permeability 
and CYP450 2D6 substrate were predicted by submitting 
each molecule individually to the admetSAR server [39]. 
2.3.5. In silico molecular docking studies  
The docking of the synthesized compounds to the binding 
pocket of glucosamine-6-phosphate synthase (GlcN-6-P) 
and P38 MAP kinase was carried out using the Autodock-
Vina program [40]. The co-crystallized structure of GlcN-
6-P (PDB ID: 2VF5) and P38 MAP kinase (PDB ID: 1OUK) 
were retrieved from protein databank, and their substrate 
binding sites were identified using pdbsum server [41, 
42]. A grid box of dimensions 40 x 50 x 40 Å with X, Y and 
Z coordinates at 32.198, 16.709 and –3.151 for GlcN-6-P 
and 56 x 60 x 48 Å with X, Y and Z coordinates at 44.746, 
34.234 and 32.603 for P38 MAPk were created respective-
ly. For the obtained molecules, all the torsions were al-
lowed to rotate during docking. The grid box was set 
around the residues forming the active pocket. The bind-
ing interactions were visualized using Biovia Discovery 
Studio Visualizer V.20.1 and Schrodinger-Maestro V.12.7. 
The in silico studies were performed on a local machine 
equipped with AMD Ryzen 5 six-core 3.4 GHz processor, 
8 GB graphics and 16 GB RAM with Microsoft Windows 10 
operating system. 
2.3.6. Computational studies 
Computational studies of synthesized compounds (3a-d) 
were conducted by using the Gaussian 09 software [43] 
with the help of the density functional theory at  
Becke-3-Lee-Yang-parr (DFT)/B3LYP level with  
6-31G (d,p) basis set [44]. The energy minimization pro-
cess has been conducted at the same level in the gas phase 
to obtain a stable structure. The 3D representation of the 
optimized structure was presented in a molecular visuali-
zation program Gauss view 5.0 and the output was pro-
cessed using the Avogadro software [45]. 
3. Results and discussion 
3.1. Chemistry  
In this report, we developed a convenient and straightfor-
ward method for the synthesis of 5-(3-substituted-
thiophene)-pyrimidine derivatives (3a-d) via Knoevenagel 
condensation of barbituric/thiobarbituric acid (1) with  
3-substituted-thiophene-2-carboxaldehyde (2) in aqueous 
ethanol using H2O2:HCl as catalyst (Scheme 1). 
A possible mechanism for the formation of  
5-(3-substituted-thiophene)-pyrimidine derivatives is 
shown in Scheme 2. Firstly, hypochlorous acid (HOCl) 
forms by the reaction of H2O2 with HCl, and it acts as a 
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powerful oxidizing agent. Then the reaction is initiated by 
the generation of carbanion 2 from active methylene com-
pound 1. The carbanion 2 attacks the carbonyl carbon of 
aldehyde 3 to form intermediate 4, which undergo subse-
quent dehydration to desired Knoevenagel product 5. HOCl 
increases the abstraction of acidic proton from active 
methylene compound and electrophilicity of carbonyl 
group of aldehydes due to hydrogen bonding. 
Firstly, we studied the effect of catalyst on the reac-
tion. In the previous reports, the same reaction was car-
ried out in the presence of different catalysts such as CuO 
NPs, PVP-Ni NPs, Fe3O4 NPs, L-tyrosine, NH2SO3H, EAN, 
Bi(NO3)3.5H2O, and also in the absence of catalyst  
(Table 1). We studied the influence of catalyst in the pro-
gress of reaction as well as on the increased product yield. 
The results were not very encouraging. Therefore, we con-
cluded that the best result was obtained in the presence of 
green halogenating catalyst 6% H2O2:HCl, where a further 
increase in the quantity of catalyst doesn't significantly 
affect reaction kinetics. 
Consequently, to study the effect of temperature on 
synthesized compound 3a, we carried out the reaction at 
room temperature, 50 °C and 80 °C (Table 2). As a result, 
an increase in the reaction temperature decreased the re-
action time from 60 to 20 and 20 to 10 min, respectively. 
Still, the yield of the product was not affected by an in-
crease in temperature. 
The structures of the intended 5-(3-substituted-
thiophene)-pyrimidine derivatives (3a-d) were confirmed 
by IR, 1H NMR, 13C NMR and HRMS spectral data. IR spec-
trum of compound 3a showed that the absorption band in 
the region 3373 cm–1 is attributed to the amide stretching 
vibration, and the absorption band at 1654 cm–1 corre-
sponds to stretching vibration of the carbonyl group 
(C=O). Another stretching vibrational band at 1529 cm–1 
corresponds to C=C bond. The 1H NMR spectrum of com-
pound 3a exhibited two singlet peaks at δ 11.21 and 11.17 
ppm, which corresponds to two NH protons of pyrimidine 
nucleus (s, 2H, NH) and another singlet peak at δ 
8.53 ppm due to CH proton (s, 1H, CH). A multiplet peak 
was observed in the range of δ 8.24–8.13 ppm, corre-
sponds to two aromatic protons (m, 2H, Ar-H) and a tri-
plet peak at 7.33–7.31 ppm due to one aromatic proton (t,  
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Scheme 2 Possible mechanism of synthesized compounds (3a-d) 
In addition, the 13C NMR spectrum of compound 3a exhib-
ited peaks at δ 163.950 and 163.453 ppm, which corre-
spond to carbonyl carbons. 
The mass spectrum showed molecular ion peak [M+H]+ 
at m/z is 221. 9054 corresponds to the molecular weight of 
compound 3a (Supporting information: S1 to S16). The 
physical and analytical data of synthesized compounds 
(3a-d) were appended in Table 3. 
3.2. Pharmacological effect 
3.2.1. Antibacterial activity 
The synthesized 5-(3-substituted-thiophene)-pyrimidine de-
rivatives (3a-d) were screened for their in vitro antibacterial 
activity at two different concentrations (20 and 40 µg/mL). 
All four compounds showed appreciable antibacterial ac-
tivity with a varied zone of inhibition in the range of 3.3 to 
3.8 and 7.1 to 7.8 mm against E. coli and 3.0 to 3.7 and 7.4 
to 7.9 mm against S. aureus, respectively (Table 4). 
Table 1 Effect of catalysts on synthesized compound 3a 
Entry Catalyst Solvent Temperature, °C Time, min Yield, % 
1 H2O2: HCl EtOH:H2O Reflux 10 96 
2 CuO NPs – RT 10 93 [46] 
3 PVP-Ni NPs Ethylene glycol Reflux 10 87 [47] 
4 Fe3O4 NPs EtOH Reflux 30 70 [48] 
5 L-tyrosine H2O RT 16 93 [49] 
6 NH2SO3H – Grinding 120 96 [50] 
7 – Ionic liquids RT 10 96 [51] 
8 Bi(NO3)35H2O EtOH Reflux 20 95 [52] 
9 – EtOH Reflux 120 89 [53] 
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Table 2 Effect of temperature on synthesized compounds 3a 
Entry Temperature, °C Time, min Yield, % 
1 RT 60 96 
2 50 20 96 
3 80 10 96 
The results revealed that compounds 3b (3.8 and 
7.8 mm) and 3d (3.7 and 7.9 mm) having electron-
donating group (methyl) on C-3 of the thiophene ring ex-
hibited the most inhibitory effect against bacterial strains 
E. coli and S. aureus, respectively, compared to the stand-
ard drug Ciprofloxacin. 
3.2.2. Cytotoxicity 
All the four synthesized compounds were investigated for 
their in vitro cytotoxicity against MCF-7 (Breast cancer) 
cell line (Fig. 2). The plot details compound concentration 
versus the survival fraction (Fig. 3). The percentages of 
cell survival of the tested compounds are listed in Table 5. 
In vitro cytotoxicity results revealed that all four com-
pounds displayed a superior selectivity against the MCF-7 
cell line. Among the compounds tested, compound 3a ex-
hibited promising cytotoxicity with a minimum cell sur-
vival range of 23.68 to 44.16% at the concentration range 
of 200 to 6.25 µg/mL. Whereas 3b, 3c and 3d displayed 
reliable selectivity at all the concentrations with cell sur-
vival ranges of 29.00 to 50.93%, 31.31 to 66.82% and 
26.95 to 53.12%, respectively. 
3.2.3. DNA binding study 
DNA binding was assessed using electronic spectroscopy. The 
UV-absorption spectral studies were employed to examine 
the binding mode of compounds to CT DNA, which involves 
the changes in absorbance and wavelength [55]. The mole-
cules are bound to DNA with two modes (covalent or non-
covalent) of binding. The covalent binding led to bathochrom-
ism and hyperchromism due to breaking the DNA structure 
when a compound interacted with DNA covalently. While in 
non-covalent binding, there are "electrostatic", "groove", and 
"intercalative" types of interactions.  
Table 4 Antibacterial activity results of synthesized  
compounds (3a-d) 
Compd. 
Zone of inhibition in mm 
Escherichia coli Staphylococcus aureus 
Concentration in µg/mL 
20 40 20 40 
3a 3.5 7.8 3.0 7.5 
3b 3.8 7.8 3.1 7.6 
3c 3.3 7.2 3.5 7.4 
3d 3.4 7.1 3.7 7.9 
Ciprofloxacin 4.0 8.0 4.2 8.4 
 
Table 3 Physical and analytical data of synthesized compounds (3a-d) 
Entry Comp. X R Product Yield (%) 
MP (oC) 
Observed Reported 







98 278–280 271 [54] 








95 302–306 – 







94 320–322 – 








96 310–312 – 
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Fig. 2 Images of anticancer study of the synthesized compounds 
(3a-d)  
 
Fig. 3 A graph of % of surviving cells of compounds (3a-d) at dif-
ferent concentration against MCF-7 cell line 
Table 5 Percentage of cell viability against MCF-7 cell line of the 





Mean cell Viability of MCF-7 
3a 3b 3c 3d 
6.25 44.16±0.76 50.93±0.42 66.82±0.41 53.12±0.34 
12.5 38.11±0.82 48.68±0.31 58.1±0.13 46.88±0.52 
25 34.09±1.2 43.72±0.52 48.6±0.23 43.93±0.42 
50 32.37±0.82 40.23±0.61 40.03±0.82 40.03±0.62 
100 30.06±0.62 36.80±0.20 37.38±0.61 37.85±0.34 
200 23.68±0.41 29.00±0.16 31.31±0.42 26.95±0.52 
Values are Mean ±SE, N=3, *P<0.01 vs. Control  
Decreased absorption (hypochromic shifts) and red-
shift (bathochromic shift) revealed the intercalative bind-
ing of compounds with DNA. Lower hypo-
chromic/hyperchromic effect with no or negligible batho-
chromic shift led to the electrostatic binding. Minor or no 
effect and, rarely, some hyperchromism show the groove 
binding [56–58]. 
The DNA binding efficiency of synthesized compounds 
(3a-d) was monitored by comparing their absorption spectra 
with and without CT DNA. The absorption spectra were car-
ried out at a fixed concentration of synthesized compounds 
and varying with DNA concentrations (25–350 µL of 
0.502510–7 to 6.067010–7 mol L–1) under the physiological 
condition of pH 7.01. The absorption spectra of all the syn-
thesized compounds (3a-d) exhibited absorption bands at 235 
to 240 nm due to π–π* transitions (Fig. 4). The Kb values of 
compounds (3a-d) are found to be 1.1216107, 1.4072107, 
1.0634107 and 3.4872107 respectively are shown in Table 6. 
These Kb values confirm that all the synthesized compounds 
interacted strongly with CT DNA. Among the four com-
pounds, compound 3d showed a prominent binding ability 
with CT DNA compared to other compounds. The absorption 
bands of the compounds were affected due to the gradual 
increase of CT DNA concentration resulting hyperchrom-
ism/hypochromism. No/or negligible blue/red shift indicates 
strong interaction of the compounds with CT DNA mainly 
through electrostatic or groove binding [59]. The kinetics and 
thermodynamics of compounds-DNA interaction in terms of 
binding constant (Kb) and Gibbs free energy change (ΔG) 
were evaluated using the classical Van't Hoff's equation,  
ΔG= –2.303RT logKb. The negative ΔG values confirmed spon-
taneous binding of compounds with CT DNA through the 
formation of stable complexes. 
3.2.4. In silico ADME-toxicology studies 
The bioavailability and drug-likeness were estimated for 
all the synthesized compounds (3a-d) based on the mo-
lecular properties. The results indicated that all the four 
compounds under study could pass through Lipinski's fil-
ter without any violation, demonstrating a positive drug-
likeness score indicating their suitability as drug-leads.  
In silico pharmacokinetic studies showed that all the mol-
ecules under investigation could penetrate the blood-brain 
barrier and are readily absorbed by the human intestine 
while they are impermeable to Caco-2, and non-substrate 
Cytochromes P450 (CYP450) group of enzymes (Table 7). 
Table 6 DNA binding results of synthesized compounds (3a-d) 
Compd. 
λmax, nm Δλmax, 
nm 
% H Kb, M–1 
ΔG, 
kJ/mol Free Bound 
3a 240 239 1 6.187910–4 1.1216107 –40.205 
3b 236 236 0 6.015710–4 1.4072107 –40.767 
3c 239 239 0 1.156010–3 1.0634107 –40.073 
3d 236 236 0 1.238810–3 3.4872107 –43.015 
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Fig. 4 The electronic absorption spectra of compounds (3a-d) in the absence and presence of increasing amounts of CT DNA. Arrow (↓) 
shows the change in the absorbance with increase the DNA concentration. Inset: plot of [DNA]/( ∈A–∈F) Vs [DNA] 
Table 7 Bioavailability, drug likeness and in silico pharmacokinetic assessment of synthesized compounds (3a-d) 
Comp. 




































































































































3a 222.224 0.2739 5 2 1 103.51 5.2698 +0.982 –0.779 +0.982 –0.873 
3b 236.251 0.6178 5 2 1 103.51 4.9763 +0.728 –0.753 +0.980 –0.889 
3c 238.291 0.6344 4 2 1 118.53 4.2229 +0.979 –0.698 +0.977 –0.871 
3d 252.318 0.9783 4 2 1 118.53 3.9143 +0.987 –0.673 +0.976 –0.886 
In silico pharmacodynamics studies revealed that all 
the four molecules are non-mutagenic, non-
tumorigenic, non-irritant, AMES non-toxic with high 
reproductive effects with possible hepatotoxicity. The 
bioactivity assessment indicated that the molecules do 
not belong to the GPCR group of ligands, do not modu-
late ion channels, non-kinase inhibitors, non-nuclear 
receptor ligands, non-protease and non-enzyme inhibi-
tors (Table 8). 
3.2.5. Structure-activity relationship (SAR) studies 
The evaluation of the antibacterial activity of the newly 
synthesized compounds (3a-d) revealed that the presence 
of electron-donating methyl group has a significant effect 
on enhancing their potency. The compounds 3b and 3d 
have a methyl group at C-3 of the thiophene ring. This 
could have improved their cell permeability, which im-
proved their activity profile compared to 3a and 3c. The 
combination of heterocyclic rings like pyrimidine and thi-
ophene is presumed to be the main reason for the pro-
found cytotoxicity of the newly synthesized compounds 
(3a-d). Furthermore, the presence of the urea group in the 
pyrimidine ring could have significantly contributed to the 
superior cytotoxicity of 3a and 3b compared to other syn-
thesized molecules. 
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3.2.6. In silico molecular docking studies  
The results revealed that compound 3b bound with GlcN-
6-P and P38 MAPk with a minimum binding energy of –7.9 
and –6.4 kcal/mol, respectively. 3a, 3d and 3c interacted 
with a binding energy of –7.6 and –6.4, –7.4 and –6.2 and 
–7.4 and –6.0 with GlcN-6-P and P38 MAPk targets, re-
spectively. The interaction of all the molecules with GlcN-
6-P and P38 MAPk were compared with antibacterial agent 
Ciprofloxacin (–7.7 kcal/mol) and anticancer agent  
5-fluorouracil (–4.7 kcal/mol) (Table 9, Fig.5). The compu-
tational methods in drug discovery have gained enormous 
importance in modern drug research. They play a critical 
role in reducing the virtual chemical space in synthesizing, 
modifying, and screening chemical drugs against a specific 
disease target. Their effectiveness can be validated using 
microbial pathogens due to their simpler and clearer cellu-
lar understandings. Similarly, cell death modalities can 
also be studied using in vitro cell culture studies, particu-
larly focusing on necrosis, apoptosis, necroptosis, au-
tophagic cell death, etc. [42]. In the present study, in silico 
molecular docking studies were performed to predict the 
most effective binding among the synthesized molecules to 
appropriate targets [60, 61]. The studied molecules 
showed remarkable binding interactions with the selected 
target proteins, supporting their remarkable antimicrobial 
and anticancer effects. 
3.2.7. DFT studies 
Frontier molecular orbitals (FMOs) containing the highest 
occupied molecular orbital (HOMO) and lowest unoccupied 
molecular orbital (LUMO), as well as the energy gap  
(ΔE = EHOMO –ELUMO) were considered to be very effective pa-
rameters in chemical quantum chemistry [62]. FMOs also 
delivered important information about chemical reactivity, 
biological activity and kinetic stability of the molecules [63]. 
The optimized HOMO and LUMO structures of synthesized 
compounds (3a-d) are shown in Fig. 6 and 7. The HOMO and 
LUMO of compounds were helpful in determining of various 
global reactivity parameters such as ionization energy  
(I = –EHOMO), electron affinity (A = –ELUMO), chemical hard-
ness (ƞ = 1/2 (I – A)), chemical softness (σ = 1/ƞ), electroneg-
ativity (χ = 1/2 (I + A)), chemical potential (µ = –χ), and elec-
trophilicity index (ω = µ2/2ƞ) helps to study about donor–
acceptor interaction and intramolecular charge transfer (ICT) 
ability of synthesized compounds [64]. 
The calculated HOMO-LUMO energies and global reac-
tivity parameters of the synthesized compounds (3a-d) are 
displayed in Table 10. A smaller HOMO-LUMO energy gap 
(ΔE) indicates a soft molecule, while a larger gap indicates 
a hard molecule. Lower energy gap, less ionization poten-
tial, electron affinity, chemical hardness, electronegativi-
ty, electrophilicity index values and more softness values 
indicate that a molecule is more chemically and biological-
ly active with low kinetic stability [65].  
 
Fig. 5 Binding interaction of compounds 3a (a and b), 3b (c and d), 
3c (e and f), and 3d (g and h) with GlcN-6-P along with standard 
drug ciprofloxacin (i and j) (a) and Binding interaction of com-
pounds 3a (a and b), 3b (c and d), 3c (e and f), and 3d (g and h) 
with P38 MAPk along with standard drug 5-fluorouracil  
(I and j) (b) 
Table 8 In silico pharmacodynamics and bioactivity assessment of synthesized compounds (3a-d) 
Comp. 






























































































































































3a NONE NONE HIGH NONE –0.590 –0.706 +0.925 –1.12 –1.58 –0.86 –1.26 –1.30 –0.69 
3b NONE NONE HIGH NONE –0.562 –0.694 +0.950 –1.07 –1.44 –0.90 –0.91 –1.32 –0.73 
3c HIGH NONE HIGH NONE –0.859 –0.731 +0.900 –1.43 –1.77 –1.41 –1.73 –1.32 –1.00 
3d HIGH NONE HIGH NONE –0.843 –0.711 +0.850 –1.35 –1.62 –1.42 –1.35 –1.34 –1.03 
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DFT studies data reveals that the energy gaps (ΔE) of 
compounds 3a, 3b, 3c and 3d are 0.16038 eV, 0.15988 eV, 
0.12799 eV and 0.12636 eV, respectively. 3a, 3b and 3c, 3d 
moleculs show nearly similar energy gap due to the simi-
lar structure. Among them 3d molecule shows less energy 
gap (0.12636 eV) and more softness value (15.8277 eV); 
hence, it is chemically more reactive compared to the oth-
er molecules. 3a molecule has more electronegative value 
(0.19923 eV); hence, it has more tendency to attract a 
bonding electron pairs compared to the other molecules. 
Table 9 Binding energies of synthesized compounds (3a-d) with 
GlcN-6-P and P38 MAPk targets 









Ciprofloxacin –7.7 5-Fluorouracil –4.7 
3a –7.6 3a –6.4 
3b –7.9 3b –6.4 
3c –7.4 3c –6.0 
3d –7.4 3d –6.2 
Conclusions 
We described a mild, easy and green protocol for synthesiz-
ing 5-(3-substituted-thiophene)-pyrimidine derivatives (3a-
d) using H2O2:HCl as a catalyst under reflux condition. This 
synthetic approach has a short reaction time, excellent 
yield, and clean reactions make this procedure a magnifi-
cent alternative to the existing methods. Furthermore, this 
method is environmentally greener and safer. The activity 
results revealed that the compounds 3b and 3d exhibited 
more potent antibacterial activity against E. coli and S. au-
reus than the standard drug Ciprofloxacin. In vitro cytotoxi-
city results disclosed the outstanding selectivity on MCF-7 
cell line, mainly compound 3a exhibiting the most effective 
cytotoxicity with a minimum cell survival range of 23.68 to 
44.16%. DNA binding results indicated that all the synthe-
sized compounds interacted strongly with CT DNA, and 
compound-DNA complexes were stabilized by electrostatic 
or groove binding. In silico ADME-toxicology results showed 
that all the four compounds are non-toxic and suitable for 
oral bioavailability and drug-likeness, indicating their suit-
ability as drug-leads. 









I, eV A, eV ƞ, eV σ, eV χ, eV µ, eV ω, eV 
D, 
Debye 
3a –0.27942 –0.11904 0.16038 0.27942 0.11904 0.08019 12.4703 0.19923 –0.19923 0.24749 4.6744 
3b –0.27411 –0.11423 0.15988 0.27411 0.11423 0.07994 12.5093 0.19417 –0.19417 0.23581 5.2238 
3c –0.25095 –0.12296 0.12799 0.25095 0.12296 0.06399 15.6274 0.18695 –0.18695 0.27310 5.4300 
3d –0.24793 –0.12157 0.12636 0.24793 0.12157 0.06318 15.8277 0.18475 –0.18475 0.27012 5.9267 
 
Fig. 6 Optimized structures of synthesized compounds (3a-d) 
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Fig. 7 DFT study of synthesized compounds (3a-d) 
In silico molecular docking results showed compound 3b 
bound with GlcN-6-P and P38 MAPk with a least binding 
energy of –7.9 and –6.4 kcal/mol, respectively. DFT study 
result revealed that the compound 3d was chemically and 
biologically more reactive with low kinetic stability due to 
less energy gap. In future, the obtained compounds can be 
used as antibiotics, anticancer agents, dyes and pigments in 
compounds as food industries. 
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